Samsung Takes Down Parts of Medical Imaging Patent at Board

July 1, 2021, 4:44 PM

Samsung Electronics Co. convinced the Patent Trial and Appeal Board that parts of Cellect LLC’s reduced imaging technology patent are invalid in an ongoing feud between the companies.

Cellect’s U.S. Patent No. 9,198,565, on an imaging device for use in medical instruments such as endoscopes, is obvious in light of two prior imaging patents, the board said in a final written decision.

Samsung asked the board to review several Cellect patents after Cellect sued the company in the U.S. District Court for the District of Colorado for infringing its patents with tablets and smartphones. The court put the ...

To read the full article log in. To learn more about a subscription click here.